Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment

Evasion of immune surveillance is an accepted hallmark of tumor progression. The production of immune suppressive mediators by tumor cells is one of the major mechanisms of tumor immune escape. Galectin-1 (Gal-1), a pivotal immunosuppressive molecule, is expressed by many types of cancer. Tumor-secr...

Full description

Saved in:
Bibliographic Details
Published in:Biomolecules (Basel, Switzerland) Switzerland), 2021-09, Vol.11 (10), p.1398
Main Authors: Huang, Yanyu, Wang, Hsiao-Chi, Zhao, Junwei, Wu, Ming-Heng, Shih, Tsung-Chieh
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Apoptosis
Binding sites
Cancer
Cytokines
Fatalities
Galectin 1 - antagonists & inhibitors
Galectin 1 - genetics
Galectin 1 - immunology
Galectin-1
Humans
Immunosurveillance
immunotherapy
Immunotherapy - trends
LLS30
Lymphocytes
Lymphoma
microenvironment
Mutation
Neoplasms - genetics
Neoplasms - immunology
Neoplasms - pathology
Neoplasms - therapy
Proteins
Receptor mechanisms
Review
Roles
Tumor cells
Tumor Escape - genetics
Tumor Escape - immunology
Tumor microenvironment
Tumor Microenvironment - genetics
Tumor Microenvironment - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c478t-68575a947745aceb36887ee776749f685c03fa910e936352c6d920fb34581e853
cites cdi_FETCH-LOGICAL-c478t-68575a947745aceb36887ee776749f685c03fa910e936352c6d920fb34581e853
container_end_page
container_issue 10
container_start_page 1398
container_title Biomolecules (Basel, Switzerland)
container_volume 11
creator Huang, Yanyu
Wang, Hsiao-Chi
Zhao, Junwei
Wu, Ming-Heng
Shih, Tsung-Chieh
description Evasion of immune surveillance is an accepted hallmark of tumor progression. The production of immune suppressive mediators by tumor cells is one of the major mechanisms of tumor immune escape. Galectin-1 (Gal-1), a pivotal immunosuppressive molecule, is expressed by many types of cancer. Tumor-secreted Gal-1 can bind to glycosylated receptors on immune cells and trigger the suppression of immune cell function in the tumor microenvironment, contributing to the immune evasion of tumors. The aim of this review is to summarize the current literature on the expression and function of Gal-1 in the human tumor microenvironment, as well as therapeutics targeting Gal-1.
doi_str_mv 10.3390/biom11101398
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e103963806ed43ed88a6e29b2b40922e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e103963806ed43ed88a6e29b2b40922e</doaj_id><sourcerecordid>2584326661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-68575a947745aceb36887ee776749f685c03fa910e936352c6d920fb34581e853</originalsourceid><addsrcrecordid>eNpdkc1rFDEUwIMottTePMuAFw8dTfIy-bgIsmi7UBFKC95CJvOmzTIzWZOZBf_7xm5btoZAHnk_frwPQt4z-hnA0C9tiCNjjDIw-hU55pzpmiv4_fogPiKnOW9oObpcDm_JEQhZYmDHZLUex2WKedluE-YcdlhdxQFzFfvq3A3o5zDVrApTNd9hdb2MMVU_g08Rp11IcRpxmt-RN70bMp4-vifk5sf369VFffnrfL36dll7ofRcS92oxhmhlGicxxak1gpRKamE6UvWU-idYRQNSGi4l53htG9BNJqhbuCErPfeLrqN3aYwuvTXRhfsw0dMt9alOfgBLTIKRoKmEjsB2GntJHLT8lZQwzkW19e9a7u0I3a-tJHc8EL6MjOFO3sbd7bUAY3kRfDpUZDinwXzbMeQPQ6DmzAu2fJGC2UKaQr68T90E5c0lVE9UMCllKxQZ3uqDDfnhP1zMYzaf8u2h8su-IfDBp7hp9XCPcRRo2s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2584326661</pqid></control><display><type>article</type><title>Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Huang, Yanyu ; Wang, Hsiao-Chi ; Zhao, Junwei ; Wu, Ming-Heng ; Shih, Tsung-Chieh</creator><creatorcontrib>Huang, Yanyu ; Wang, Hsiao-Chi ; Zhao, Junwei ; Wu, Ming-Heng ; Shih, Tsung-Chieh</creatorcontrib><description>Evasion of immune surveillance is an accepted hallmark of tumor progression. The production of immune suppressive mediators by tumor cells is one of the major mechanisms of tumor immune escape. Galectin-1 (Gal-1), a pivotal immunosuppressive molecule, is expressed by many types of cancer. Tumor-secreted Gal-1 can bind to glycosylated receptors on immune cells and trigger the suppression of immune cell function in the tumor microenvironment, contributing to the immune evasion of tumors. The aim of this review is to summarize the current literature on the expression and function of Gal-1 in the human tumor microenvironment, as well as therapeutics targeting Gal-1.</description><identifier>ISSN: 2218-273X</identifier><identifier>EISSN: 2218-273X</identifier><identifier>DOI: 10.3390/biom11101398</identifier><identifier>PMID: 34680031</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antineoplastic Agents - therapeutic use ; Apoptosis ; Binding sites ; Cancer ; Cytokines ; Fatalities ; Galectin 1 - antagonists &amp; inhibitors ; Galectin 1 - genetics ; Galectin 1 - immunology ; Galectin-1 ; Humans ; Immunosurveillance ; immunotherapy ; Immunotherapy - trends ; LLS30 ; Lymphocytes ; Lymphoma ; microenvironment ; Mutation ; Neoplasms - genetics ; Neoplasms - immunology ; Neoplasms - pathology ; Neoplasms - therapy ; Proteins ; Receptor mechanisms ; Review ; Roles ; Tumor cells ; Tumor Escape - genetics ; Tumor Escape - immunology ; Tumor microenvironment ; Tumor Microenvironment - genetics ; Tumor Microenvironment - immunology</subject><ispartof>Biomolecules (Basel, Switzerland), 2021-09, Vol.11 (10), p.1398</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-68575a947745aceb36887ee776749f685c03fa910e936352c6d920fb34581e853</citedby><cites>FETCH-LOGICAL-c478t-68575a947745aceb36887ee776749f685c03fa910e936352c6d920fb34581e853</cites><orcidid>0000-0001-7992-1504</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2584326661/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2584326661?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25728,27898,27899,36986,36987,44563,53763,53765,75093</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34680031$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Yanyu</creatorcontrib><creatorcontrib>Wang, Hsiao-Chi</creatorcontrib><creatorcontrib>Zhao, Junwei</creatorcontrib><creatorcontrib>Wu, Ming-Heng</creatorcontrib><creatorcontrib>Shih, Tsung-Chieh</creatorcontrib><title>Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment</title><title>Biomolecules (Basel, Switzerland)</title><addtitle>Biomolecules</addtitle><description>Evasion of immune surveillance is an accepted hallmark of tumor progression. The production of immune suppressive mediators by tumor cells is one of the major mechanisms of tumor immune escape. Galectin-1 (Gal-1), a pivotal immunosuppressive molecule, is expressed by many types of cancer. Tumor-secreted Gal-1 can bind to glycosylated receptors on immune cells and trigger the suppression of immune cell function in the tumor microenvironment, contributing to the immune evasion of tumors. The aim of this review is to summarize the current literature on the expression and function of Gal-1 in the human tumor microenvironment, as well as therapeutics targeting Gal-1.</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Apoptosis</subject><subject>Binding sites</subject><subject>Cancer</subject><subject>Cytokines</subject><subject>Fatalities</subject><subject>Galectin 1 - antagonists &amp; inhibitors</subject><subject>Galectin 1 - genetics</subject><subject>Galectin 1 - immunology</subject><subject>Galectin-1</subject><subject>Humans</subject><subject>Immunosurveillance</subject><subject>immunotherapy</subject><subject>Immunotherapy - trends</subject><subject>LLS30</subject><subject>Lymphocytes</subject><subject>Lymphoma</subject><subject>microenvironment</subject><subject>Mutation</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - pathology</subject><subject>Neoplasms - therapy</subject><subject>Proteins</subject><subject>Receptor mechanisms</subject><subject>Review</subject><subject>Roles</subject><subject>Tumor cells</subject><subject>Tumor Escape - genetics</subject><subject>Tumor Escape - immunology</subject><subject>Tumor microenvironment</subject><subject>Tumor Microenvironment - genetics</subject><subject>Tumor Microenvironment - immunology</subject><issn>2218-273X</issn><issn>2218-273X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkc1rFDEUwIMottTePMuAFw8dTfIy-bgIsmi7UBFKC95CJvOmzTIzWZOZBf_7xm5btoZAHnk_frwPQt4z-hnA0C9tiCNjjDIw-hU55pzpmiv4_fogPiKnOW9oObpcDm_JEQhZYmDHZLUex2WKedluE-YcdlhdxQFzFfvq3A3o5zDVrApTNd9hdb2MMVU_g08Rp11IcRpxmt-RN70bMp4-vifk5sf369VFffnrfL36dll7ofRcS92oxhmhlGicxxak1gpRKamE6UvWU-idYRQNSGi4l53htG9BNJqhbuCErPfeLrqN3aYwuvTXRhfsw0dMt9alOfgBLTIKRoKmEjsB2GntJHLT8lZQwzkW19e9a7u0I3a-tJHc8EL6MjOFO3sbd7bUAY3kRfDpUZDinwXzbMeQPQ6DmzAu2fJGC2UKaQr68T90E5c0lVE9UMCllKxQZ3uqDDfnhP1zMYzaf8u2h8su-IfDBp7hp9XCPcRRo2s</recordid><startdate>20210923</startdate><enddate>20210923</enddate><creator>Huang, Yanyu</creator><creator>Wang, Hsiao-Chi</creator><creator>Zhao, Junwei</creator><creator>Wu, Ming-Heng</creator><creator>Shih, Tsung-Chieh</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7992-1504</orcidid></search><sort><creationdate>20210923</creationdate><title>Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment</title><author>Huang, Yanyu ; Wang, Hsiao-Chi ; Zhao, Junwei ; Wu, Ming-Heng ; Shih, Tsung-Chieh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-68575a947745aceb36887ee776749f685c03fa910e936352c6d920fb34581e853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Apoptosis</topic><topic>Binding sites</topic><topic>Cancer</topic><topic>Cytokines</topic><topic>Fatalities</topic><topic>Galectin 1 - antagonists &amp; inhibitors</topic><topic>Galectin 1 - genetics</topic><topic>Galectin 1 - immunology</topic><topic>Galectin-1</topic><topic>Humans</topic><topic>Immunosurveillance</topic><topic>immunotherapy</topic><topic>Immunotherapy - trends</topic><topic>LLS30</topic><topic>Lymphocytes</topic><topic>Lymphoma</topic><topic>microenvironment</topic><topic>Mutation</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - pathology</topic><topic>Neoplasms - therapy</topic><topic>Proteins</topic><topic>Receptor mechanisms</topic><topic>Review</topic><topic>Roles</topic><topic>Tumor cells</topic><topic>Tumor Escape - genetics</topic><topic>Tumor Escape - immunology</topic><topic>Tumor microenvironment</topic><topic>Tumor Microenvironment - genetics</topic><topic>Tumor Microenvironment - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Yanyu</creatorcontrib><creatorcontrib>Wang, Hsiao-Chi</creatorcontrib><creatorcontrib>Zhao, Junwei</creatorcontrib><creatorcontrib>Wu, Ming-Heng</creatorcontrib><creatorcontrib>Shih, Tsung-Chieh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Biomolecules (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Yanyu</au><au>Wang, Hsiao-Chi</au><au>Zhao, Junwei</au><au>Wu, Ming-Heng</au><au>Shih, Tsung-Chieh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment</atitle><jtitle>Biomolecules (Basel, Switzerland)</jtitle><addtitle>Biomolecules</addtitle><date>2021-09-23</date><risdate>2021</risdate><volume>11</volume><issue>10</issue><spage>1398</spage><pages>1398-</pages><issn>2218-273X</issn><eissn>2218-273X</eissn><abstract>Evasion of immune surveillance is an accepted hallmark of tumor progression. The production of immune suppressive mediators by tumor cells is one of the major mechanisms of tumor immune escape. Galectin-1 (Gal-1), a pivotal immunosuppressive molecule, is expressed by many types of cancer. Tumor-secreted Gal-1 can bind to glycosylated receptors on immune cells and trigger the suppression of immune cell function in the tumor microenvironment, contributing to the immune evasion of tumors. The aim of this review is to summarize the current literature on the expression and function of Gal-1 in the human tumor microenvironment, as well as therapeutics targeting Gal-1.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34680031</pmid><doi>10.3390/biom11101398</doi><orcidid>https://orcid.org/0000-0001-7992-1504</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2218-273X
ispartof Biomolecules (Basel, Switzerland), 2021-09, Vol.11 (10), p.1398
issn 2218-273X
2218-273X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e103963806ed43ed88a6e29b2b40922e
source Publicly Available Content Database; PubMed Central
subjects Antineoplastic Agents - therapeutic use
Apoptosis
Binding sites
Cancer
Cytokines
Fatalities
Galectin 1 - antagonists & inhibitors
Galectin 1 - genetics
Galectin 1 - immunology
Galectin-1
Humans
Immunosurveillance
immunotherapy
Immunotherapy - trends
LLS30
Lymphocytes
Lymphoma
microenvironment
Mutation
Neoplasms - genetics
Neoplasms - immunology
Neoplasms - pathology
Neoplasms - therapy
Proteins
Receptor mechanisms
Review
Roles
Tumor cells
Tumor Escape - genetics
Tumor Escape - immunology
Tumor microenvironment
Tumor Microenvironment - genetics
Tumor Microenvironment - immunology
title Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-25T23%3A23%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunosuppressive%20Roles%20of%20Galectin-1%20in%20the%20Tumor%20Microenvironment&rft.jtitle=Biomolecules%20(Basel,%20Switzerland)&rft.au=Huang,%20Yanyu&rft.date=2021-09-23&rft.volume=11&rft.issue=10&rft.spage=1398&rft.pages=1398-&rft.issn=2218-273X&rft.eissn=2218-273X&rft_id=info:doi/10.3390/biom11101398&rft_dat=%3Cproquest_doaj_%3E2584326661%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-68575a947745aceb36887ee776749f685c03fa910e936352c6d920fb34581e853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2584326661&rft_id=info:pmid/34680031&rfr_iscdi=true